Literature DB >> 12467573

Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography.

Jacek Nowakowski1, Ciarán N Cronin, Duncan E McRee, Mark W Knuth, Christian G Nelson, Nikola P Pavletich, Joe Rogers, Bi-Ching Sang, Daniel N Scheibe, Ronald V Swanson, Devon A Thompson.   

Abstract

Protein kinases are important drug targets in human cancers, inflammation, and metabolic diseases. This report presents the structures of kinase domains for three cancer-associated protein kinases: ephrin receptor A2 (EphA2), focal adhesion kinase (FAK), and Aurora-A. The expression profiles of EphA2, FAK, and Aurora-A in carcinomas suggest that inhibitors of these kinases may have inherent potential as therapeutic agents. The structures were determined from crystals grown in nanovolume droplets, which produced high-resolution diffraction data at 1.7, 1.9, and 2.3 A for FAK, Aurora-A, and EphA2, respectively. The FAK and Aurora-A structures are the first determined within two unique subfamilies of human kinases, and all three structures provide new insights into kinase regulation and the design of selective inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467573     DOI: 10.1016/s0969-2126(02)00907-3

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  53 in total

Review 1.  The role of Eph receptors in lens function and disease.

Authors:  Alexander I Son; Jeong Eun Park; RenPing Zhou
Journal:  Sci China Life Sci       Date:  2012-05-27       Impact factor: 6.038

2.  A change in conformational dynamics underlies the activation of Eph receptor tyrosine kinases.

Authors:  Silke Wiesner; Leanne E Wybenga-Groot; Neil Warner; Hong Lin; Tony Pawson; Julie D Forman-Kay; Frank Sicheri
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

3.  Production of selenomethionyl-derivatized proteins in baculovirus-infected insect cells.

Authors:  Ciarán N Cronin; Kheng B Lim; Joe Rogers
Journal:  Protein Sci       Date:  2007-07-27       Impact factor: 6.725

4.  Molecular distinctions between Aurora A and B: a single residue change transforms Aurora A into correctly localized and functional Aurora B.

Authors:  Fabienne Hans; Dimitrios A Skoufias; Stefan Dimitrov; Robert L Margolis
Journal:  Mol Biol Cell       Date:  2009-06-03       Impact factor: 4.138

5.  Structure-based design of Aurora A & B inhibitors.

Authors:  Anders Poulsen; Anthony William; Angeline Lee; Stéphanie Blanchard; Eeling Teo; Weiping Deng; Noah Tu; Evelyn Tan; Eric Sun; Kay Lin Goh; Wai Chung Ong; Chee Pang Ng; Kee Chuan Goh; Zahid Bonday
Journal:  J Comput Aided Mol Des       Date:  2008-06-24       Impact factor: 3.686

6.  Structural studies of B-type Aurora kinase inhibitors using computational methods.

Authors:  Mm Neaz; M Muddassar; Fa Pasha; Seung Joo Cho
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

7.  Exploring the mechanistic insights of Cas scaffolding protein family member 4 with protein tyrosine kinase 2 in Alzheimer's disease by evaluating protein interactions through molecular docking and dynamic simulations.

Authors:  Mubashir Hassan; Saba Shahzadi; Hany Alashwal; Nazar Zaki; Sung-Yum Seo; Ahmed A Moustafa
Journal:  Neurol Sci       Date:  2018-05-22       Impact factor: 3.307

8.  Structural basis for the autoinhibition of focal adhesion kinase.

Authors:  Daniel Lietha; Xinming Cai; Derek F J Ceccarelli; Yiqun Li; Michael D Schaller; Michael J Eck
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

9.  Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.

Authors:  Julie M Kneller; Thomas Ehlen; Jasenka P Matisic; Dianne Miller; Dirk Van Niekerk; Wan L Lam; Marco Marra; Rebecca Richards-Kortum; Michelle Follen; Calum Macaulay; Steven J M Jones
Journal:  Biomark Insights       Date:  2007-12-11

10.  EPHA2 is associated with age-related cortical cataract in mice and humans.

Authors:  Gyungah Jun; Hong Guo; Barbara E K Klein; Ronald Klein; Jie Jin Wang; Paul Mitchell; Hui Miao; Kristine E Lee; Tripti Joshi; Matthias Buck; Preeti Chugha; David Bardenstein; Alison P Klein; Joan E Bailey-Wilson; Xiaohua Gong; Tim D Spector; Toby Andrew; Christopher J Hammond; Robert C Elston; Sudha K Iyengar; Bingcheng Wang
Journal:  PLoS Genet       Date:  2009-07-31       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.